Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Bip_osteopearl_vcf_lenoss
Biological kyphoplasty / VCF — OsteoPearl cortical allograft & Elevoss cavity system

Cortical allograft kyphoplasty without PMMA—commercial early with Series A traction.

NEMIC + Commerce voucher—growth equity, not university OTL formation.

Entity: Lenoss MedicalPatents: 7Stage: commercial early us
US10993756B2US12029463B2USD1106456S1USD1106457S1US10219851B1US20250099150A1
Open dossier
Tier Aip_pax_aav_vegf_tendon
AAV2–VEGF gene therapy for tendon & ligament repair (PAX-001)

One-shot gene therapy at repair—faster, stronger tendon healing than surgery alone.

RIH-origin patents + ~$1.7M seed + RILSH LIFT for IND—physician-chairman Liu MD with pre-IND complete.

Entity: Pax TherapeuticsPatents: 1Stage: preclinical ind enabling
WO2019146830A1Source
Open dossier
Tier Bip_af_mapping_ai
AI-guided atrial fibrillation ablation mapping (VX1)

FDA-cleared AI AF ablation mapping—growth-stage SaMD with protected claims.

~€74M VC path—strategic or growth round, not formation.

Entity: Volta MedicalPatents: 2Stage: fda cleared commercial
US10750967B2US20210121118A1
Open dossier
Tier Bip_oncolux_lumis
LUMIS optical theranostics — intraoperative see-and-treat oncology

See malignant margins and treat in the same OR workflow—AI-guided optical theranostics.

RILSH attraction award + Ocean State Labs + Mayo know-how—medtech growth, not university OTL.

Entity: OncoLuxPatents: 3Stage: clinical validation
US20260083330A1US20250076201A1US20240310617A1Source
Open dossier
Tier APatent gapgap_soma_dtx
SOMA interoception / pain digital therapeutic

COBRE-backed interoception pain DTx—spinout forming from Carney.

Kaia-class financing vs Pear Ch.11 payer lesson—SaMD path after pivotal pilot.

Entity: SOMASciencePatents: —Stage: preclinical grant
P20GM103645PMID 33378658
Open dossier
Tier APatent gapgap_levine_pediatric_sepsis
Wearable pediatric sepsis ML (Levine / Garbern)

Wearable ML for earlier pediatric sepsis recognition—validated in Bangladesh ICU cohort.

FIC R33TW012211 → US SaMD path; pairs with RIH RNA Dx stack.

Patents: —Stage: preclinical grant
R33TW012211R01DK116163D43TW012768PMID 39475844PMID 41252746
Open dossier
Tier APatent gapgap_rih_salivary_ev_ad
Salivary EV biomarkers for Alzheimer's disease (RIH)

Salivary extracellular vesicles as a non-invasive Alzheimer's liquid biopsy.

RIH/Brown R01AG074284 supports analytical development; path to CLIA LDT then spinout.

Patents: 1Stage: preclinical grant
US20260103757A1R01AG074284PMID 41602168
Open dossier
Tier APatent gapgap_rih_bx912_pulmonary_htn
BX-912 for pulmonary hypertension (RIH)

BX-912 program for pulmonary hypertension—RIH PCT with multi-center inventor team.

Preclinical PH models → IND-enabling; benchmark against 2024 PAH biologic approval.

Patents: 1Stage: preclinical grant
WO2026112526A1R01HL174007
Open dossier
Tier APatent gapgap_rih_pahtn_dx
PAH / sudden cardiac death diagnostics (RIH)

RIH diagnostic panel for pulmonary arterial hypertension and sudden cardiac death risk.

Mature US20180094317 family; retrospective → prospective validation.

Patents: 1Stage: preclinical grant
US20180094317A1R01HL174007R01HL141268R01HL104025
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.